| Fund ID | 805-9088549222 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | Yes |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 5% |
| Owned by funds of funds | 55% |
| Owned by non-U.S. persons | 27% |
| Fund | Type | Gross assets |
|---|---|---|
| Intandem Capital Partners Fund III, LP | Private Equity | $521.4M |
| Intandem Capital Partners Fund II, LP | Private Equity | $511.5M |
| Intandem Capital Opportunities Fund, LP | Private Equity | $510.8M |
Itc Infusion Co-Invest II, LP reports $178.3 million in gross assets, among the top 32% of private funds by size.
The stated minimum investment is $50,000.
Itc Infusion Co-Invest II, LP is managed by Intandem Capital Partners, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.